Stock screener

ARQT

Conviction 59HealthcareScan · Thu, Sep 24, 2026

Arcutis Biotherapeutics, Inc. (ARQT) closed at $26.28 (-0.38%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 55, RS Rating 89, -15.8% from its 52-week high, -9.4% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

ARQT$26.28-0.38%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
2
3
Vol MA14 4.39M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Arcutis Biotherapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.arcutis.com ↗
Price26.28
Change-0.38%
Gap+0.27%
Rel volume1.88×
Avg volume3.55M
Avg $ vol89.41M
SMA 2024.77
SMA 5025.88
SMA 20025.31
Price vs 50+1.54%
Price vs 200+3.85%
MA stackbullish
50/200 cross—
Supertrendup · 22.87
RSI (14)55
MACD hist0.35
MACD crossbull · 8d
Stoch %K / %D61 / 72
ADX (14)21
+DI / −DI28 / 16
RSI divergence—
MACD divergence—
ATR %5.12%
ADR %4.81%
52w high31.20
52w low16.73
From 52w high-15.77%
Above 52w low+57.08%
New 52w highNo
SqueezeOff
Bollinger width20.27%
%B0.80
Donchian pos61.27%
Donchian high28.29
Donchian low23.10
AVWAP (52w high)25.32
vs AVWAP high+3.80%
AVWAP (52w low)24.99
vs AVWAP low+5.16%
OBV trendDown
Chaikin MF (20)-0.08
Today vs 20d1.88×
Avg vol (14d)4.39M
Avg vol (20d)3.55M
Avg $ vol (20d)89.41M
Market cap3.3B
RS Rating89 / 99
RS 3m (vs SPY)-6.03%
RS 6m (vs SPY)-1.25%
RS line new highNo
Trend template4/8
Technical rank76.3
1 week-0.68%
1 month+5.71%
3 months-1.54%
6 months+15.57%
1 year+49.32%
YTD-9.38%
P/E-204.65
P/B14.98
P/S8.78
P/FCF-523.40
EPS-0.1300
Div yield—
ROE-7.32%
ROA-3.30%
Debt/Eq0.49
Current2.92
EV/EBITDA—
Gross margin—
Net margin-4.29%
Rev growth91.34%
EPS growth88.47%
Price target36.67
Target upside39.54%
Analyst ratingBuy
Institutional112.34%
Ent. value3.38B
Revenue129.86M
Net income15.01M
Gross profit—
Free cash flow-6.31M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out125.08M
Employees354
ListedFri, Jan 31, 2020
Free float109.34M
Float %89.3%
Short interest16.56M
Days to cover9.4d
Short volume70.3%
Squeeze score88 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.11 vs $0.09
Last surprise+22.2% beat
Setup gradeC
Conviction59 / 100
Pattern quality—
Tech rank76.3 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance28.77
Support23.19
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ARQT · 1 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-05-29
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in ARQT · open-market 2 sells

InsiderSideShares
Welgus Howard G.
Director · Common Stock · 2026-09-15
Exercise822
Welgus Howard G.
Director · Common Stock · 2026-09-15
Exercise1.02K
Welgus Howard G.
Director · Common Stock · 2026-09-15
Exercise2.25K
Welgus Howard G.
Director · Common Stock · 2026-09-15
Sell4.73K
Welgus Howard G.
Director · Stock Option (right to buy) · 2026-09-15
Exercise822
Welgus Howard G.
Director · Stock Option (right to buy) · 2026-09-15
Exercise1.02K
Welgus Howard G.
Director · Stock Option (right to buy) · 2026-09-15
Exercise2.25K
Curran Terrie
Director · Common Stock · 2026-08-27
Exercise11.15K
Curran Terrie
Director · Common Stock · 2026-08-27
Sell11.15K
Curran Terrie
Director · Common Stock · 2026-08-27
Exercise27.05K

SEC filings

EDGAR filings in ARQT · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.